PubRank

I A Campbell

Author PubWeight™ 78.22‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000 3.68
2 Audit of a tuberculosis contact tracing clinic. BMJ 1992 2.80
3 Detecting and reducing hospital adverse events: outcomes of the Wimmera clinical risk management program. Med J Aust 2001 2.61
4 What is the optimum duration of anticoagulation for the management of patients with idiopathic deep venous thrombosis and pulmonary embolism? J R Coll Physicians Edinb 2010 2.36
5 Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle 1977 2.35
6 Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J (Clin Res Ed) 1984 1.83
7 Survey of pulmonary tuberculosis in south and west Wales (1976-8). Br Med J (Clin Res Ed) 1982 1.78
8 Anticoagulants in venous thromboembolism. BMJ 1988 1.77
9 Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax 2001 1.67
10 Oxygen as a driving gas for nebulisers: safe or dangerous? Br Med J (Clin Res Ed) 1984 1.60
11 Management of spontaneous pneumothorax-a Welsh survey. Postgrad Med J 2000 1.53
12 Interaction between isoprenaline and aminophylline in asthma. Thorax 1977 1.52
13 Pulmonary infection with mycobacterium xenopi: review of treatment and response. Thorax 1984 1.50
14 Twice daily slow-release theophylline vs placebo for 'morning-dipping' in asthma. Br J Clin Pharmacol 1984 1.48
15 Lymph node tuberculosis: a comparison of treatments 18 months after completion of chemotherapy. Tubercle 1979 1.40
16 "Opportunist" mycobacterial infections. Thorax 2000 1.39
17 Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Thorax 2008 1.37
18 Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex. Thorax 1981 1.35
19 Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response. Thorax 1983 1.32
20 Monitoring effects of oral anticoagulants during treatment with heparin. Br Med J (Clin Res Ed) 1984 1.18
21 Management of extra-pulmonary tuberculosis (excluding miliary and meningeal) in south and west Wales (1976-8). Br Med J (Clin Res Ed) 1982 1.11
22 Humidifier fever in an operating theatre. Br Med J 1979 1.07
23 Tuberculosis contact tracing: are the British Thoracic Society guidelines still appropriate? Thorax 1992 1.07
24 Stopping smoking. Do nicotine chewing-gum and postal encouragement add to doctors' advice. Practitioner 1987 1.05
25 A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis. Br J Dis Chest 1982 1.04
26 Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support. Thorax 2002 1.03
27 Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results. Respir Med 1993 1.02
28 A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism. Clin Lab Haematol 1987 1.00
29 Effect of a "stop smoking" booklet on smokers attending for chest radiography: a controlled study. Thorax 1986 0.98
30 Guidelines to control heparin treatment. Br Med J (Clin Res Ed) 1986 0.94
31 Vitamin A absorption in cystic fibrosis: risk of hypervitaminosis A. Gut 1992 0.93
32 Refined tuberculosis contact tracing in a low incidence area. Respir Med 1998 0.92
33 Retrospective survey of the management of miliary tuberculosis in South and West Wales, 1976-8. Thorax 1983 0.87
34 Costs and getting ethical approval deter doctors from participating in multicentre trials. BMJ 1996 0.87
35 Audit of control of heparin treatment. Br Med J (Clin Res Ed) 1985 0.85
36 Thromboembolism related to a Port-a-Cath device in a patient with cystic fibrosis. Thorax 1997 0.85
37 Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma. Br J Clin Pharmacol 1986 0.84
38 Neutropenia with each standard antituberculosis drug in the same patient. Br Med J 1980 0.84
39 Letter: Ethambutol and the eye; zinc and copper. Lancet 1975 0.83
40 Intermittent positive-pressure breathing. Br Med J 1978 0.82
41 Intrabronchial metastases from renal carcinoma with recurrent tumour expectoration. Thorax 1981 0.82
42 Use of flutter VRP1 in the management of patients with steroid-dependent asthma. Respiration 1994 0.81
43 Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment. Respir Med 2003 0.81
44 Acute myeloid leukaemia presenting with pleural effusions. Clin Lab Haematol 1989 0.81
45 Dielectric investigation of the temperature dependence of the nonexponentiality of the dynamics of polymer melts. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 1999 0.81
46 Totally implantable venous access devices in adult patients with cystic fibrosis. Respir Med 1996 0.80
47 Attitudes to smoking and smoking habits among hospital staff. Thorax 1993 0.80
48 A smoking cessation counsellor: should every hospital have one? J R Soc Promot Health 1998 0.80
49 Ordering in Heisenberg spin glasses. Phys Rev Lett 2002 0.80
50 Indoramin--an alpha adrenoreceptor antagonist for airway obstruction. Br J Dis Chest 1977 0.79
51 Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax 1984 0.79
52 Active surveillance for tuberculosis in Wales: 1996-2003. Arch Dis Child 2006 0.78
53 Determinants of free theophylline clearance in asthma. Br J Clin Pharmacol 1987 0.78
54 Vitamin D receptor gene polymorphisms and susceptibility to Mycobacterium malmoense pulmonary disease. J Infect Dis 2000 0.78
55 Nutrition in adults with cystic fibrosis. Clin Nutr 1998 0.78
56 Acute haemodynamic effects of nifedipine at rest and during maximal exercise in patients with chronic cor pulmonale. Thorax 1985 0.77
57 Proton magnetic resonance studies of histidines in human, rhesus monkey, and bovine carbonic anhydrases. Biochim Biophys Acta 1977 0.76
58 CD1 genotyping of patients with Mycobacterium malmoense pulmonary disease. Tissue Antigens 2001 0.76
59 Antituberculosis drug levels after jejunoileal bypass. Br J Dis Chest 1982 0.76
60 Plasma theophylline concentrations. Br Med J (Clin Res Ed) 1985 0.75
61 Late complication of plombage thoracoplasty. Thorax 1985 0.75
62 Clinical presentation and investigation of patients proceeding to isotope lung scanning for suspected pulmonary embolism. Postgrad Med J 1990 0.75
63 Nicotine patches in general practice. BMJ 1993 0.75
64 How to intervene against smoking. J R Coll Physicians Lond 2000 0.75
65 Aggressive psychosis in AIDS patient on high-dose steroids. Lancet 1987 0.75
66 A re-appraisal of warfarin control in the treatment of deep vein thrombosis and / or pulmonary embolism. Afr Health Sci 2009 0.75
67 Safety profile of bupropion for chronic obstructive pulmonary disease. Lancet 2001 0.75
68 Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy. Tuber Lung Dis 1995 0.75
69 Comparison of salmefamol and salbutamol in patients with chronic airways obstruction. Br J Clin Pharmacol 1976 0.75
70 Toxicity of isoniazid and rifampicin combination. Thorax 1995 0.75
71 Psoas abscess following ingestion of psoas. Aust N Z J Surg 1992 0.75
72 Survey of flexible working amongst specialist registrars and consultants in respiratory medicine in the UK. Clin Med 2005 0.75
73 Pituitary hormones in diabetic ketoacidosis. Lancet 1978 0.75
74 Inhaled steroids and dysphonia. Lancet 1984 0.75
75 Studies in cutaneous immunofluorescence. I. The effect of storage time on direct immunofluorescence of skin biopsies from bullous disease and lupus erythematosus. J Cutan Pathol 1980 0.75
76 Short-course chemotherapy in pulmonary tuberculosis. Bull Int Union Tuberc 1976 0.75
77 Ethambutol and the eye. Lancet 1988 0.75
78 Tuberculosis outbreak among Rastafarians in Birmingham. Lancet 1985 0.75
79 Triple therapy with isoniazid, rifampicin and pyrazinamide. Bull Int Union Tuberc Lung Dis 1988 0.75
80 Smoking control and cessation. Br J Nurs 1993 0.75
81 Unusual clinical signs complicating tension haemothorax. Br J Dis Chest 1984 0.75
82 Fortuin-Kasteleyn and damage-spreading transitions in random-bond Ising lattices. Phys Rev E Stat Nonlin Soft Matter Phys 2012 0.75
83 An assessment of prilocaine as a topical anaesthetic agent for fibreoptic bronchoscopy in comparison with lidocaine. Acta Anaesthesiol Scand 1994 0.75
84 Mycobacterium avium disease: progress at last. Am J Respir Crit Care Med 1996 0.75
85 Auger injuries in the Wimmera region 1987-95. Aust N Z J Surg 1996 0.75
86 Pulmonary veno-occlusive disease and Hodgkin's lymphoma. Eur Respir J 1993 0.75
87 Infrarenal aortic aneurysm surgery in a rural surgical service: risk factors for mortality. Aust N Z J Surg 1998 0.75
88 Suppression of plasma neutrophil elastase-alpha1-anti-proteinase complex by adequate replacement therapy in a patient with acquired hypogammaglobulinemia. J Allergy Clin Immunol 1997 0.75
89 Oxygen as a driving gas for nebulizers: safe or dangerous. Br Med J (Clin Res Ed) 1984 0.75
90 Management of asthma with beclomethasone dipropionate. A comparison of pressurized aerosol and rotahaler powder inhalation. Practitioner 1982 0.75
91 Letter: Peak-flow meter v. peak-flow gauge. Lancet 1974 0.75
92 Candida albicans infection complicating percutaneous gastrostomy in cystic fibrosis. Br J Clin Pract 1995 0.75
93 Peak-flow meter versus peak-flow gauge. Lancet 1974 0.75
94 Proceedings: Comparison of two bronchodilators--salmefamol and salbutamol. Tubercle 1975 0.75
95 Proceedings: Inhaled corticosteroids compared with oral prednisone in asthmatic patients commencing regular corticosteroids. Tubercle 1975 0.75
96 Ising ferromagnet in dimension five: link and spin overlaps. Phys Rev E Stat Nonlin Soft Matter Phys 2013 0.75